Outcomes of patients with schizophrenia who discontinued long‐acting injectable antipsychotic therapy due to adverse events: A chart review

Outcomes of patients with schizophrenia who discontinued long‐acting injectable antipsychotic therapy due to adverse events: A chart review

Abstract Aim We conducted a chart review to investigate the detailed outcomes of patients with schizophrenia who discontinued long‐acting injectable second‐generation antipsychotic (LAI‐SGA) therapy due to adverse events (AEs). Methods The study included patients with schizophrenia and related psych...

Full description

Bibliographic Details
Main Authors: Taro Kishi, Kenji Sakuma, Makoto Okuya, Masakazu Hatano, Nakao Iwata
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Neuropsychopharmacology Reports
Subjects:
adverse events
long‐acting injectable second‐generation antipsychotic
schizophrenia
Online Access:https://doi.org/10.1002/npr2.12192

Internet

https://doi.org/10.1002/npr2.12192

Similar Items